1092 THE DISSOLUTION PROCEDURE: DEVELOPMENT AND …
The use of enzymes in the dissolution medium is permitted in accordance with Dissolution 711 when dissolution failures occur as a result of cross-linking with gelatin capsules or gelatin-coated products. In Vitro–In Vivo Correlation (IVIVC) An in-depth discussion on IVIVC can be found in In Vitro and In Vivo Evaluation of Dosage Forms 1088 ...
Download 1092 THE DISSOLUTION PROCEDURE: DEVELOPMENT AND …
Information
Domain:
Source:
Link to this page:
Documents from same domain
MONOGRAPHS (USP) - uspnf.com
www.uspnf.comProcedure—Transfer a sufficient portion of Test solution A and Test solution B to separate test tubes of colorless, transparent, neutralglass withaflatbaseandaninternaldia-
Stearic Acid M - uspnf.com
www.uspnf.comStage 6 Harmonization Official May 1, 2016 Stearic 1. = molecular weight of potassium hydroxide, Stearic Acid M r 56.11 NF34 Acceptance criteria: 194–212 Portions of this monograph that are national USP text, and • C. The retention times of the major peaks of the Sample are not part of the harmonized text, are marked with solution correspond …
Injections and Implanted Drug Products (Parenterals ...
www.uspnf.comLarge-volume injections for single-dose infusion, small-Aqueous vehicles—Aqueous vehicles must meet the require- volume injections, and pharmacy bulk packages (PBPs) arements of 〈151〉 or 〈85〉, whichever is specified in the mono-
Compendial Approvals for USP42-NF37 1S
www.uspnf.comCompendial Approvals for USP42-NF37 1S Category Monograph Title Monograph Section Scientific Liaison Revision
<788> PARTICULATE MATTER IN INJECTIONS - uspnf.com
www.uspnf.comsize. The definition for particle-free water is provided in Reagent Specifications under Reagents, Indicators and Solution section. The apparatus is calibrated using dispersions of …
DISSOLUTION - USP-NF
www.uspnf.comRevision Bulletin 4 〈711〉 Dissolution Official February 1, 2012 flow rates of 4, 8, and 16 mL per minute. It must deliver a constant flow (±5% of the nominal flow rate); the flow pro-file is sinusoidal with a pulsation of 120±10 pulses per
General Notices and Requirements - uspnf.com
www.uspnf.com4 General Notices USP 32 3.10.10. Applicability of Standards to Drug Products, Drugarticle.For general requirements relating to specific monograph Substances, and Excipients sections, see section 5, Monograph Components. The applicable USP or NF standard applies to any article mar-Because monographs may not provide standards for all relevant keted in the United States that (1) is …
Levetiracetam Tablets - uspnf.com
www.uspnf.comRevision Bulletin 2 Levetiracetam Official May 1, 2011 Sample solution: Pass a portion of the solution under test Mode: LC through a suitable filter. Dilute an aliquot with Medium to Detector: UV 200 nm obtain a concentration similar to that of the Standard Column: 4.6-mm × 25-cm; 4-µm packing L1 solution.
Residual Solvents: ICH Q3C Impurities: Residual Solvents
www.uspnf.comheadspace analysis, solid-phase microextraction, and direct injection of solution containing bulk drug substance or drug product into the gas chromatograph. zIn conclusion, gas chromatograph-based procedures will continue to dominate residual solvent testing because of its specificity for
General Chapter Injections Correction - USP-NF
www.uspnf.comtherapeutic efficacy or with the responses to the specified assaysmore than 1 L are labeled to indicate that the contents are not in- ... tices and Antimicrobial Effectiveness Testing 〈51〉). remains uncovered for its full length or circumference to permit in- ... the section Preservation, Packaging, Storage, and Labeling of the
Related documents
Annex 7 - WHO
www.who.intAnnex 7 133 10.3.3 Dissolution profile comparison for biowaivers based on dose- proportionality of formulations 177 10.4 In vitro equivalence testing for non-oral dosage forms 177 10.5 In vitro equivalence testing for scale-up and post-approval changes 180 References 180 Appendix 1 Recommendations for conducting and assessing comparative
ASEAN GUIDELINE FOR THE CONDUCT OF BIOEQUIVALENCE …
asean.orgproduct with regards to dissolution and assay content has been selected. It is advisable to investigate more than one single batch of the comparator product when selecting comparator product batch for the bioequivalence study. Test product The test product used in the study should be representative of the product to be
DECISION TREE #1: ESTABLISHING ACCEPTANCE CRITERION …
database.ich.orgFOR DRUG PRODUCT DISSOLUTION 3. What are appropriate acceptance ranges? [extended release] YES NO NO YES YES NO YES NO Are bioavailability data available for batches with different drug release rates? Is drug release independent of in vitro test conditions? Can an in vitro / in vivo relationship be established? (Modify in vitro test conditions ...